PoliticalRepoPoliticalRepo

United Kingdom · Question · Written question

UIN 45044

Tixagevimab/cilgavimab

Original

answeredUnited Kingdom· UK Parliament· EN

Introduced

2 September 2022

Last action

27 September 2022 · Answer

Status

Answered

Sponsors

Subjects

Discovery layer

Source updated

27 September 2022

Summary

To ask the Secretary of State for Health and Social Care, if he will publish (a) the full clinical and scientific advice that his Department received on Evusheld and (b) his Department's reasoning for its decision not to procure the drug for treatment of

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 2 September 2022

    Written question

    To ask the Secretary of State for Health and Social Care, if he will publish (a) the full clinical and scientific advice that his Department received on Evusheld and (b) his Department's reasoning for its decision not to procure the drug for treatment of

    Source: Commons

  2. 27 September 2022

    Answer

    The Government has decided not to procure Evusheld for prevention through emergency routes at this time. This is a decision based on independent clinical advice by the multi-agency initiative, RAPID C-19 and a national expert policy working group. These g...

    Source: Written answer

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.